The Role of Standardized Bleeding Score in Diagnosis of Pediatric Von Willebrand's Disease
NCT04849338 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2021-04-19
Summary
Von Willebrand's disease (VWD) is the most common inherited bleeding disorder. It arises from a deficiency in the quality or quantity of von Willebrand factor (VWF), a multimeric protein that is required for platelet adhesion. Typical patients present with mucocutaneous bleeding symptoms because of reduced circulating von Willebrand factor (VWF) In this study we will use the ISTH/SSC BLEEDING assessment tool as a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders
Conditions
- Von Willebrand's Diseased Children, Bleeding Questionnaire is Done
Interventions
- DIAGNOSTIC_TEST
-
Bleeding score ( questionnaire )
Bleeding score is done for children diagnosed as von Willebrand's disease .
Sponsors & Collaborators
-
Sohag University
lead OTHER
Eligibility
- Min Age
- 1 Week
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-04-15
- Primary Completion
- 2022-05-15
- Completion
- 2022-05-15
Countries
- Egypt
Study Locations
More Related Trials
-
Collection of Blood in Normal Subjects and Subjects With Von Willebrand Disease (VWD)
NCT00630448 ·Status: WITHDRAWN
-
A Study of Factor Inhibitors in Adult Patients With Hemophilia and Von Willebrand's Disease in Upper Egypt
NCT04106323 ·Status: UNKNOWN
-
Genetic Background of Patients With Low Von Willebrand Factor Levels
NCT05116501 ·Status: UNKNOWN ·Phase: NA
-
Real-life Data of Constitutional Von Willebrand Disease in Western France
NCT04887324 ·Status: COMPLETED
-
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
NCT01410227 ·Status: COMPLETED ·Phase: PHASE3
-
Gingival Bleeding and Von Willebrand Disease Typ 2 and 3
NCT03078595 ·Status: COMPLETED
-
Phase I Study of Human Von Willebrand Factor for Von Willebrand's Disease
NCT00004667 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy, PK, Immunogenicity and Safety of Wilate in Severe Von Willebrand Disease (VWD) Patients <6 Years of Age
NCT04953884 ·Status: COMPLETED ·Phase: PHASE3
-
Bleeding Incidence in VWD Patients Undergoing On-Demand Treatment
NCT04053699 ·Status: COMPLETED
-
Survey of Inhibitors in Plasma-Product Exposed Toddlers
NCT01064284 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Bleeding and Treatment in Participants With Von Willebrand Disease
NCT06610201 ·Status: RECRUITING
-
World Bleeding Disorders Registry Pilot Study
NCT02776826 ·Status: COMPLETED
-
Study of Biostate® in Children With Von Willebrand Disease
NCT01213446 ·Status: COMPLETED ·Phase: PHASE3
-
Extension Study of Biostate in Subjects With Von Willebrand Disease
NCT01224808 ·Status: COMPLETED ·Phase: PHASE3
-
Von Willebrand Factor in Pregnancy (VIP) Study
NCT04146376 ·Status: RECRUITING
-
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
NCT00816660 ·Status: COMPLETED ·Phase: PHASE1
-
Type 3 Von Willebrand International Registries Inhibitor Prospective Study
NCT02460458 ·Status: COMPLETED
-
Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD)
NCT00168090 ·Status: COMPLETED ·Phase: PHASE4
-
Algorithm-based Management to Reduce the Recurrence of GI Bleeding and Severe Epistaxis in Von Willebrand Disease
NCT06651255 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of Fanhdi®, a High-purity Von Willebrand Containing FVIII Concentrate, in Pediatric Patients With Von Willebrand Disease
NCT02472665 ·Status: WITHDRAWN ·Phase: PHASE4
-
The Von Willebrand Disease (VWD) International Prophylaxis Study
NCT00557908 ·Status: COMPLETED
-
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
NCT02932618 ·Status: COMPLETED ·Phase: PHASE3
-
National Study of Moderate and Severe Von Willebrand Disease in the Netherlands
NCT00510042 ·Status: COMPLETED
-
A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)
NCT05582993 ·Status: RECRUITING ·Phase: PHASE3
-
Severe Pregnancy Complications Are Associated With Elevated Factor VIII Plasma Activity
NCT00573118 ·Status: UNKNOWN